In vitro interactions of approved and experimental drugs against Candida drugs against Candida spp.
Repp
K K
KK
Cancer Research Institute, Arizona State University, Tempe. Arizona 85287-2404, USA.
Hogan
F
F
Pettit
G R
GR
Pettit
R K
RK
D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology*; D001230:Aspergillus / Q000187:drug effects*; D001555:Benzene Derivatives / Q000494:pharmacology; D002176:Candida albicans / Q000187:drug effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005030:Ethylenes / Q000494:pharmacology; D005437:Flucytosine / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests; D009842:Oligopeptides / Q000494:pharmacology
C462659:1-(3',4',5'-trimethoxyphenyl)-2-nitroethylene; D000935:Antifungal Agents; D001555:Benzene Derivatives; D005030:Ethylenes; D009842:Oligopeptides; C482455:auristatin PHE; D000666:Amphotericin B; D005437:Flucytosine